{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T16:09:28Z","timestamp":1771430968403,"version":"3.50.1"},"reference-count":39,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Union\u2019s NextGenerationEU economic recovery package via the National Recovery and Resilience Plan of the Republic of Bulgari","award":["BG-RRP-2.004-0004-C01"],"award-info":[{"award-number":["BG-RRP-2.004-0004-C01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Resistance to apoptosis represents a major limitation of platinum-based chemotherapy in colorectal carcinoma, frequently arising from impaired p53 signaling and inefficient execution of programmed cell death. In this study, we investigated the anticancer activity of Erica spiculifolia extract (ESE) and its ability to synergistically enhance cisplatin cytotoxicity in HT-29 colorectal carcinoma cells. Cell viability was assessed using the MTT assay, followed by formal combination analysis based on the Chou\u2013Talalay methodology. Combination experiments employed a non-constant ratio regimen in which a fixed ESE concentration (45 \u00b5g\/mL) was combined with serial cisplatin dilutions (45.0\u20132.8 \u00b5g\/mL) to define interaction behavior across multiple effect levels. Quantitative analysis revealed a strong superadditive effect, with Combination Index values well below 1 and markedly elevated Dose Reduction Indices for cisplatin, indicating substantial dose-sparing across effect levels. To elucidate the molecular basis of this synergism, apoptosis-related protein expression was profiled using a membrane-based immunoassay. Combined ESE and cisplatin treatment induced full-scale p53 reactivation, including restoration of phosphorylated p53 isoforms associated with DNA damage-dependent apoptotic signaling. Acridine orange\/propidium iodide staining confirmed a pronounced increase in early and late apoptotic\/necrotic cells following combination treatment. UHPLC-HRMS analysis identified kaempferol 3-O-glucoside (8830.19 \u00b1 11.01 ng\/mg dw) and myricitrin (3074 \u00b1 3.12 ng\/mg) as predominant flavonols, followed by naringenin 7-O-glucoside (5958.96 \u00b1 9.98 ng\/mg), while chlorogenic, cinnamic, quinic, and gallic acids were the main phenolic acids detected. These constituents may contribute to HT-29 cell sensitization to cisplatin.<\/jats:p>","DOI":"10.3390\/molecules31040710","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T15:28:18Z","timestamp":1771428498000},"page":"710","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Erica spiculifolia Extract Potentiates Cisplatin Cytotoxicity by Reactivating p53 and Caspase-3-Dependent Apoptosis in Colorectal Carcinoma"],"prefix":"10.3390","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5763-0730","authenticated-orcid":false,"given":"Rositsa","family":"Mihaylova","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolay","family":"Bebrivenski","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1952-9903","authenticated-orcid":false,"given":"Dimitrina","family":"Zheleva-Dimitrova","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4860-9053","authenticated-orcid":false,"given":"Rumyana","family":"Simeonova","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7748-4133","authenticated-orcid":false,"given":"Vesela","family":"Lozanova","sequence":"additional","affiliation":[{"name":"Department of Medical Chemistry and Biochemistry, Faculty of Medicine, Medical University\u2013Sofia, 1000 Sofia, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralitza","family":"Alexova","sequence":"additional","affiliation":[{"name":"Department of Medical Chemistry and Biochemistry, Faculty of Medicine, Medical University\u2013Sofia, 1000 Sofia, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7528-590X","authenticated-orcid":false,"given":"Vanyo","family":"Mitev","sequence":"additional","affiliation":[{"name":"Department of Medical Chemistry and Biochemistry, Faculty of Medicine, Medical University\u2013Sofia, 1000 Sofia, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1254-2419","authenticated-orcid":false,"given":"Reneta","family":"Gevrenova","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2841-7089","authenticated-orcid":false,"given":"Georgi","family":"Momekov","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","article-title":"Global patterns and trends in colorectal cancer incidence and mortality","volume":"66","author":"Arnold","year":"2017","journal-title":"Gut"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"101174","DOI":"10.1016\/j.tranon.2021.101174","article-title":"Global colorectal cancer burden in 2020 and projections to 2040","volume":"14","author":"Xi","year":"2021","journal-title":"Transl. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41392-024-01953-7","article-title":"Signaling pathways involved in colorectal cancer: Pathogenesis and targeted therapy","volume":"9","author":"Li","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Haynes, J., and Manogaran, P. (2025). Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26051988"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Bai, B., Ma, Y., Liu, D., Zhang, Y., Zhang, W., Shi, R., and Zhou, Q. (2024). DNA damage caused by chemotherapy has duality, and traditional Chinese medicine may be a better choice to reduce its toxicity. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1483160"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"K\u00f6berle, B., and Schoch, S. (2021). Platinum Complexes in Colorectal Cancer and Other Solid Tumors. Cancers, 13.","DOI":"10.3390\/cancers13092073"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Marin, J.J.G., Macias, R.I.R., Monte, M.J., Herraez, E., Peleteiro-Vigil, A., Blas, B.S.D., Sanchon-Sanchez, P., Temprano, A.G., Espinosa-Escudero, R.A., and Lozano, E. (2020). Cellular Mechanisms Accounting for the Refractoriness of Colorectal Carcinoma to Pharmacological Treatment. Cancers, 12.","DOI":"10.3390\/cancers12092605"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Liebl, M.C., and Hofmann, T.G. (2021). The Role of p53 Signaling in Colorectal Cancer. Cancers, 13.","DOI":"10.3390\/cancers13092125"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1186\/s12967-025-06566-4","article-title":"p53 in colorectal cancer: From a master player to a privileged therapy target","volume":"23","author":"Yan","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Sun, L., Li, Y., Wang, M., Luo, L., Sun, R., Chen, Y., Bai, Y., Ding, C., and Wang, Y. (2024). p53 deficiency mediates cisplatin resistance by upregulating RRM2 and crotonylation of RRM2K283 through the downregulation of SIRT7. Front. Mol. Biosci., 11.","DOI":"10.3389\/fmolb.2024.1423594"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Therachiyil, L., Haroon, J., Sahir, F., Siveen, K.S., Uddin, S., Kulinski, M., Buddenkotte, J., Steinhoff, M., and Krishnankutty, R. (2020). Dysregulated Phosphorylation of p53, Autophagy and Stemness Attributes the Mutant p53 Harboring Colon Cancer Cells Impaired Sensitivity to Oxaliplatin. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.01744"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Li, Q., Tong, Y., Chen, J., and Xie, T. (2024). Targeting programmed cell death via active ingredients from natural plants: A promising approach to cancer therapy. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1491802"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"10732748241302902","DOI":"10.1177\/10732748241302902","article-title":"Phytochemicals in Cancer Chemoprevention: Preclinical and Clinical Studies","volume":"31","author":"Lekhak","year":"2024","journal-title":"Cancer Control"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"115473","DOI":"10.1016\/j.biopha.2023.115473","article-title":"Natural products and mitochondrial allies in colorectal cancer therapy","volume":"167","author":"Wei","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Costea, T., Vlad, O.C., Miclea, L.-C., Ganea, C., Sz\u00f6ll\u0151si, J., and Mocanu, M.-M. (2020). Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21020401"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1080\/14786419.2023.2301677","article-title":"Antioxidative and anti-inflammatory activities of Erica spiculifolia extracts and fractions","volume":"39","year":"2025","journal-title":"Natural Product. Res."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Jabal, K.A., Pigott, M., Sheridan, H., and Walsh, J.J. (2025). Mediterranean Basin Erica Species: Traditional Uses, Phytochemistry and Pharmacological Properties. Molecules, 30.","DOI":"10.20944\/preprints202505.2367.v1"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Gevrenova, R., Szakiel, A., P\u0105czkowski, C., Zengin, G., Kurt-Celep, I., Stefanova, A., and Zheleva-Dimitrova, D. (2025). Erica spiculifolia Salisb. (Balkan Heath): A Focus on Metabolic Profiling and Antioxidant and Enzyme Inhibitory Properties. Plants, 14.","DOI":"10.3390\/plants14111648"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Gevrenova, R., Mihaylova, R., Bebrivenski, N., Momekov, G., and Zheleva-Dimitrova, D. (2025). Insight into Cytotoxic Potential of Erica spiculifolia Salisb (Balkan Heath). Plants, 14.","DOI":"10.3390\/plants14193063"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"180442","DOI":"10.1098\/rsos.180442","article-title":"Anastasis: Recovery from the brink of cell death","volume":"5","author":"Tang","year":"2018","journal-title":"R. Soc. Open Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41419-023-05916-8","article-title":"Anastasis enhances metastasis and chemoresistance of colorectal cancer cells through upregulating cIAP2\/NF\u03baB signaling","volume":"14","author":"Wang","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"36611","DOI":"10.1074\/jbc.M200317200","article-title":"Proteasome-mediated Degradation of Smac during Apoptosis: XIAP Promotes Smac Ubiquitination In Vitro","volume":"277","author":"MacFarlane","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1038\/sj.cdd.4401959","article-title":"Livin promotes Smac\/DIABLO degradation by ubiquitin\u2013proteasome pathway","volume":"13","author":"Ma","year":"2006","journal-title":"Cell Death Differ."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Yang, M., Li, W.-Y., Xie, J., Wang, Z.-L., Wen, Y.-L., Zhao, C.-C., Tao, L., Li, L.-F., Tian, Y., and Sheng, J. (2021). Astragalin Inhibits the Proliferation and Migration of Human Colon Cancer HCT116 Cells by Regulating the NF-\u03baB Signaling Pathway. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.639256"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1007\/s11033-021-06500-z","article-title":"Apoptotic mechanisms of myricitrin isolated from Madhuca longifolia leaves in HL-60 leukemia cells","volume":"48","author":"Sarkar","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Villota, H., Santa-Gonz\u00e1lez, G.A., Uribe, D., Henao, I.C., Arroyave-Ospina, J.C., Barrera-Causil, C.J., and Pedroza-D\u00edaz, J. (2022). Modulatory Effect of Chlorogenic Acid and Coffee Extracts on Wnt\/\u03b2-Catenin Pathway in Colorectal Cancer Cells. Nutrients, 14.","DOI":"10.3390\/nu14224880"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"6783","DOI":"10.3390\/cimb46070405","article-title":"A Comprehensive View on the Impact of Chlorogenic Acids on Colorectal Cancer","volume":"46","author":"Maghiar","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"9845","DOI":"10.1007\/s11033-023-08854-y","article-title":"Chlorogenic acid induces apoptosis and cell-cycle arrest in colorectal cancer cells","volume":"50","author":"Ranjbary","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4103\/pm.pm_36_18","article-title":"Quinic acid attenuates oral cancer cell proliferation by downregulating cyclin D1 Expression and Akt signaling","volume":"14","author":"Singh","year":"2018","journal-title":"Pharmacogn. Mag."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Abd-Rabou, A.A., Shalby, B.A., and Ahmed, H.H. (2016). Anti-cancer activity of quercetin, gallic acid, and ellagic acid against hepg2 and hct 116 cell lines: In vitro. Int. J. Pharm. Bio Sci., 7.","DOI":"10.22376\/ijpbs.2016.7.4.b584-592"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/toxres\/tfad041","article-title":"Gallic acid: A polyphenolic compound potentiates the therapeutic efficacy of cisplatin in human breast cancer cells","volume":"12","author":"Shruthi","year":"2023","journal-title":"Toxicol. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"103654","DOI":"10.1016\/j.jpet.2025.103654","article-title":"Cinnamic acid enhances vinorelbine-induced cytotoxicity in MDA-MB-231 cells through modulation of PTEN and ATG5 expression","volume":"392","author":"Jasem","year":"2025","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"20815","DOI":"10.1039\/D5RA02640G","article-title":"Recent advances in nano vehicles encapsulating cinnamic acid and its derivatives as promising anticancer agents","volume":"15","author":"Nafie","year":"2025","journal-title":"RSC Adv."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.15430\/JCP.24.013","article-title":"Kaempferol Synergistically Enhances Cisplatin-induced Apoptosis and Cell Cycle Arrest in Colon Cancer Cells","volume":"29","author":"Haroon","year":"2024","journal-title":"J. Cancer Prev."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Almatroudi, A., Allemailem, K.S., Alwanian, W.M., Alharbi, B.F., Alrumaihi, F., Khan, A.A., Almatroodi, S.A., and Rahmani, A.H. (2023). Effects and Mechanisms of Kaempferol in the Management of Cancers through Modulation of Inflammation and Signal Transduction Pathways. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24108630"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"26941","DOI":"10.18632\/oncotarget.15264","article-title":"Astragalin-induced cell death is caspase-dependent and enhances the susceptibility of lung cancer cells to tumor necrosis factor by inhibiting the NF-\u03baB pathway","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.3892\/ijo.2015.3133","article-title":"Myricetin inhibits proliferation of cisplatin-resistant cancer cells through a p53-dependent apoptotic pathway","volume":"47","author":"Huang","year":"2015","journal-title":"Int. J. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/14728222.2024.2306345","article-title":"Myricetin, a natural inhibitor of CD147, increases sensitivity of cisplatin in ovarian cancer","volume":"28","author":"Chen","year":"2024","journal-title":"Expert Opin. Ther. Targets"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/31\/4\/710\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T15:28:29Z","timestamp":1771428509000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/31\/4\/710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["molecules31040710"],"URL":"https:\/\/doi.org\/10.3390\/molecules31040710","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]}}}